XML 39 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Statements of Cash Flows - USD ($)
12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Cash Flows from Operating Activities      
Net income (loss) $ (8,274,236) $ (6,159,424) $ 3,519,312
Adjustments to reconcile net income (loss) to net cash provided by operations      
Depreciation and amortization 8,947,039 8,649,702 8,114,306
Distributions in excess of earnings from equity method investments 272,049 232,353 244,183
Gain on sale of asset 0 0 (11,793)
Non-cash patronage income (249,058) (365,854) (192,094)
Change in working capital components      
Accounts receivable (1,645,848) 1,522,025 1,301,533
Inventories 701,335 (687,985) (421,803)
Derivative instruments 473,146 (142,686) (259,913)
Prepaids and other (74,648) (1,462) (32,152)
Accounts payable 2,813,174 1,361,072 28,171
Accrued expenses (5,302) (13,760) 160,963
Net cash provided by operating activities 2,957,651 4,393,981 12,450,713
Cash Flows from Investing Activities      
Capital expenditures (1,709,039) (2,274,830) (5,137,921)
Proceeds from sale of asset 0 0 18,523
Net cash used in investing activities (1,709,039) (2,274,830) (5,119,398)
Cash Flows from Financing Activities      
Payments on long-term debt (14,001,000) (3,250,000) (6,485,166)
Advances on long-term debt 14,000,000 2,500,000 0
Member unit repurchases (39,200) (16,000) (550,000)
Member distributions 0 (1,660,658) (1,687,740)
Net cash used in financing activities (40,200) (2,426,658) (8,722,906)
Net Increase (decrease) in Cash and Cash Equivalents 1,208,412 (307,507) (1,391,591)
Cash and cash equivalents – Beginning of Period 430,702 738,209 2,129,800
Cash and cash equivalents – End of Period 1,639,114 430,702 738,209
Supplemental Cash Flow Information      
Cash paid for interest expense 761,920 568,345 585,348
Supplemental Disclosure of Noncash Financing and Investing Activities      
Capital expenditures included in accounts payable $ 13,214 $ 67,990 $ 44,216